Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak Setting
Not Applicable
Completed
- Conditions
- Mycoplasma Pneumoniae
- Registration Number
- NCT00207584
- Lead Sponsor
- Centers for Disease Control and Prevention
- Brief Summary
This study was designed to determine whether taking daily doxycycline during an outbreak of Mycoplasma pneumoniae could prevent a person from getting infected and interrupt ongoing disease transmission during an outbreak. Doxycycline is a treatment for Mycoplasma pneumoniae, but it is not certain that the drug could prevent disease if used prophylactically.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Working at hospital facility where outbreak of Mycoplasma pneumoniae occured
Exclusion Criteria
- Pregnant, on antiseizure medications, allergic to macrolide antibiotics
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method